Related Experiment Video

Updated: May 27, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
14:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

p53 modulates acquired resistance to EGFR inhibitors and radiation

Shyhmin Huang1, Sergio Benavente, Eric A Armstrong

  • 1Department of Human Oncology, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin 53792, USA.

Cancer Research
|November 10, 2011
PubMed

Insights

Restoring the tumor suppressor p53 can overcome acquired resistance to epidermal growth factor receptor (EGFR) inhibitors and radiation in cancer. This finding suggests p53 restoration as a potential therapeutic strategy.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Epidermal growth factor receptor (EGFR) inhibitors are widely used to treat various cancers.
  • Acquired resistance to these therapies is a significant clinical challenge.
  • Understanding resistance mechanisms is crucial for improving cancer treatment outcomes.

Purpose of the Study:

  • To investigate the mechanisms of acquired resistance to EGFR inhibitors.
  • To determine the role of the p53 tumor suppressor protein in this resistance.
  • To explore p53 restoration as a strategy to overcome resistance.

Main Methods:

  • Established EGFR inhibitor-resistant cancer cell lines (non-small cell lung cancer).
  • Utilized p53 knockdown and restoration experiments.
  • Assessed sensitivity to EGFR inhibitors and radiation in vitro and in vivo.

Main Results:

  • Acquired resistance to EGFR inhibitors was consistently associated with p53 loss and cross-resistance to radiation.
  • p53 knockdown reduced sensitivity to both EGFR inhibitors and radiation.
  • Restoring p53 resensitized resistant cells to EGFR inhibitors and radiation.

Conclusions:

  • p53 plays a central role in acquired resistance to EGFR inhibitors and radiation.
  • p53 may enhance sensitivity through cell-cycle arrest, apoptosis, and DNA repair.
  • p53 restoration strategies warrant consideration in clinical trials combining EGFR inhibitors and radiation.

More Related Videos

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...